Stay updated with breaking news from David Augustsson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Oncopeptides announces successful price negotiations for Pepaxti in GermanyStockholm – September 26, 2023 – Oncopeptides AB (publ), a biotech company focused on difficult-to-treat cancers, today announces that following negotiations between Oncopeptides and the German Federal Joint Committee National Ass...
Oncopeptides launches Oncopeptalks with a fireside chat featuring CEO Sofia Heigis September 20, 2023 Join David Augustsson, Director, Corporate Affairs at...
New information regarding Oncopeptides' appeal of U.S. withdrawal published Additional information regarding the formal request from the U.S. Food and Drug Administration to...
September 12, 2023 A new article, describing a set of affibody-based NK cell engagers using B cell maturation antigen as a model antigen for targeting of...
June 19, 2023 Oncopeptides today announced its first named patient sales of its flagship drug Pepaxti in Greece. The sales were made possible through... | June 19, 2023